Last update:

Diseases, Conditions, Syndromes news

Medications

FDA approves injectable Ocrevus Zunovo for relapsing, progressive multiple sclerosis

The U.S. Food and Drug Administration has approved Ocrevus Zunovo (ocrelizumab and hyaluronidase-ocsq) as the first and only twice-a-year, 10-minute subcutaneous injection for people with relapsing and progressive multiple ...

Diseases, Conditions, Syndromes

Study confirms effectiveness of the new omicron booster

The autumn wave of coronavirus is sweeping across Germany. Those affected mainly suffer from coughs, colds, sore throats and fever, but also from headaches, aching limbs, general weakness and shortness of breath. Because ...

Diseases, Conditions, Syndromes

Microfluidic chip brings hope for sepsis prognosis and evaluation

A research team led by Associate Professor Yang Ke from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, in collaboration with the First Affiliated Hospital of Anhui Medical University, developed ...

Diseases, Conditions, Syndromes

Q&A: Shedding light on a neglected form of sickle cell disease

Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major protein that carries oxygen in red blood cells. It occurs in nearly 100,000 people in the United States ...

Medications

EU watchdog puts sickle cell disease drug on ice

The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, saying doctors should stop using the drug.

Diseases, Conditions, Syndromes

Mpox vaccine rollout faces challenges in east DR Congo

Mpox epicenter DR Congo is less than a week away from the start of a vaccination campaign, but the rollout faces challenges in a vast country with limited roads, often in poor condition.

Diseases, Conditions, Syndromes

Cannabidiol demonstrated to alleviate symptoms of Leigh syndrome

A study led by the UAB Institut de Neurociències and published in the journal Nature Communications demonstrates in animal models how daily administration of cannabidiol (CBD), a substance obtained from the cannabis plant, ...

Diseases, Conditions, Syndromes

Health agencies scramble to prepare for new mpox strain

State and federal health agencies are gearing up to respond to a new strain of mpox—the virus formerly known as monkeypox—if the new strain spreads to the United States.

Diseases, Conditions, Syndromes

Mpox epicenter DRC receives first vaccines to contain outbreak

The Democratic Republic of Congo, the epicenter of an mpox outbreak, on Thursday received its first vaccines—almost half of 200,000 doses donated by the European Union and due to arrive by the end of the week to fight ...

Diseases, Conditions, Syndromes

Monoclonal antibody tops placebo for reducing migraine frequency

The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing migraine frequency over four weeks, according to a ...

Diseases, Conditions, Syndromes

Lower-carbon concrete floors could pave the way to a health solution

Unlike dirt floors common in some rural parts of the world, concrete floors are easily cleaned of disease-carrying pathogens—but they come at a high environmental cost. A lower-carbon flooring mix could provide a solution.

Diseases, Conditions, Syndromes

Chronic skin disorder risk reduces over smoke-free years

The University of Cincinnati's Robert Van Haren was featured in a MedCentral article discussing recent research that found smoking cessation significantly reduced the risk of developing hidradenitis suppurativa, a non-contagious ...

Diseases, Conditions, Syndromes

Q&A: What you need to know about the latest mpox outbreak

Mpox clade I, one of two types of the virus formerly called monkeypox, is spreading quickly in Africa. Mpox clade I causes more severe illness and death than the other type—mpox clade 2. More than 18,000 cases have been ...